Pfizer
Olivia Green is a Health & Science Professional specializing in Cardiovascular & Internal Medicine at Pfizer, contributing expertise to products such as Eliquis, Nurtec ODT, and Paxlovid since April 2024. Prior experience includes roles at The Dedham Group as Associate Consultant, Senior Analyst, and Analyst from January 2022 to April 2024, as well as serving as an OnSite Specialist in Endoscopy at Stryker, where Olivia provided clinical support to surgical teams and managed endoscopy sales. At UAB Medicine, Olivia was a Clinical Research Assistant involved in the development of an Autism Consultation Clinic and participated in research presentation at national conferences. Early career experiences include a pre-medical internship at Children's of Alabama and a distinguished tenure as a ballet dancer with the American Ballet Theatre, where Olivia earned a Silver Medal at the Youth America Grand Prix. Olivia holds dual Bachelor of Arts degrees in Psychology from Barnard College and Columbia University, along with a High School Diploma with Honors from the Professional Children's School.
Pfizer
605 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.